Compare ALLO & BMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALLO | BMM |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 27 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 654.0M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | BMM |
|---|---|---|
| Price | $2.06 | $6.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 7.8M | 112.7K |
| Earning Date | 05-07-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $3.47 |
| 52 Week High | $4.46 | $8.63 |
| Indicator | ALLO | BMM |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 38.71 |
| Support Level | $1.85 | $4.79 |
| Resistance Level | $2.36 | $6.56 |
| Average True Range (ATR) | 0.13 | 0.56 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 74.12 | 2.73 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Blue Moon Metals Inc is a Canadian exploration stage company which is focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The company also holds the Yava polymetallic project in Nunavut that is in the same volcanic lithologies and south of Glencore's Hackett River deposit. The company is focusing on advancing the Blue Moon and Yava properties.